| Oxford
GlycoSciences, plc ( LSE:OGS) is the world’s leading proteomics company. OGS is
developing gene-protein linked database products in human, plant, microbial and animal
systems for application across the pharma and biotech industry. Certain non-exclusive
database products are being commercialized on a subscription basis with Incyte
Pharmaceuticals or through exclusive research collaborations with third parties. The
Company also constructs exclusive databases of protein expression for select clients. In
addition to the exclusive deal with Pioneer, OGS is also constructing databases for Pfizer
and diaDexus. |
